Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jun 21, 2025; 31(23): 106261
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.106261
Table 1 Baseline characteristics of the patients, n (%)

ESD (n = 15)
STER (n = 10)
LWR (n = 25)
P value
Age, years, median (IQR)53.0 (40.0-57.5)43.0 (39.0-57.0)56.0 (43.0-64.0)0.347
Sex 0.618
    Male6 (40.0)6 (60.0)12 (48.0)
    Female9 (60.0)4 (40.0)13 (52.0)
Preoperative symptoms0.252
    None12 (80.0)8 (80.0)24 (96.0)
    Abdominal discomfort2 (13.3)2 (20.0)0 (0.0)
    Chest discomfort1 (6.7)0 (0.0)1 (4.0)
Location0.013
    EGJ1 (6.7)4 (40.0)1 (4.0)
    Cardia, AW side4 (26.7)0 (0.0)5 (20.0)
    Cardia, PW side6 (40.0)6 (60.0)17 (68.0)
    Cardia, fundal side4 (26.7)0 (0.0)2 (8.0)
Long diameter of tumor, mm, median (IQR)118.0 (15.5-23.0)21.0 (17.0-23.0)30.0 (25.6-36.0)< 0.001
Regularity20.885
    Regular9 (60.0)5 (50.0)14 (56.0)
    Irregular6 (40.0)5 (50.0)11 (44.0)
    Echogenicity0.113
Hypoechoic-homogenous12 (80.0)8 (80.0)13 (52.0)
Hypoechoic-heterogeneous3 (20.0)2 (20.0)12 (48.0)
Layer origin30.114
    Inner muscle layer15 (100.0)10 (100.0)21 (84.0)
    Outer muscle layer0 (0.0)0 (0.0)4 (16.0)
Tumor type
Intraluminal growing type15 (100.0)10 (100.0)25 (100.0)1.000
Table 2 Peri-operative clinical outcomes, n (%)

ESD (n = 15)
STER (n = 10)
LWR (n = 25)
P value
En bloc resection15 (100.0)10 (100.0)25 (100.0)1.000
Macroscopic complete resection115 (100.0)10 (100.0)25 (100.0)1.000
Microscopic complete resection20.021
    R0 resection13 (86.7)6 (60.0)24 (96)
    R1 resection2 (13.3)4 (40.0)1 (4.0)
Pathological diagnosis< 0.001
    Leiomyoma10 (66.7)9 (90.0)8 (32.0)
    GIST with low-risk33 (20.0)0 (0.0)0 (0.0)
    GIST with intermediate to high-risk42 (13.3)1 (10.0)17 (68.0)
Total procedure time, minutes, median (IQR)75.0 (65.0-100.0)84.0 (73.0-92.0)70.0 (55.0-80.0)0.075
Hospital stay, days, median (IQR)6.0 (5.0-7.0)6.0 (6.0-9.0)5.0 (4.0-6.0)0.017
Fasting duration, days, median (IQR)2.0 (2.0-5.0)3.0 (3.0-4.0)1.0 (1.0-1.0)< 0.001
Long diameter of tumor in pathology, mm, median (IQR)27.0 (15.5-35.0)28.5 (25.0-45.0)36.0 (27.0-45.0)0.002
Complications
    Delayed bleeding2 (13.3)0 (0.0)1 (4.0)0.325
    Pneumoperitoneum52 (13.3)0 (0.0)1 (4.0)0.325
    Peritonitis0 (0.0)0 (0.0)0 (0.0)1.000
Table 3 Postoperative clinical outcomes, n (%)

ESD (n = 15)
STER (n = 10)
LWR (n = 25)
P value
Follow up period, median (IQR)60.0 (26.5-66.5)24.0 (13.0-38.0)35.0 (21.0-60.0)0.065
Tumor recurrence0 (0.0)0 (0.0)1 (4.0)0.600
Death0 (0.0)0 (0.0)0 (0.0)1.000
Table 4 Association between significant complications and clinicopathological characteristics, n (%)

Without significant complication, 45 (90.0)1
With significant complication, 5 (10.0)1
RR (95%CI)
P value
Age, years
    < 6537 (82.2)5 (100.0)1 (reference)
    ≥ 658 (17.8)0 (0.0)1.27 (0.55-2.95)
Sex0.706
    Male22 (48.9)2 (40.0)1 (reference)
    Female23 (51.1)3 (60.0)0.94 (0.43-2.06)
Location0.006
    EGJ or non-fundal side on cardia29 (64.4)0 (0.0)1 (reference)
    Cardia, fundal side16 (35.6)5 (100.0)1.13 (0.53-2.45)
Tumor size32.0 (25.0-40.0)34.0 (32.0-35.0)0.637
    < 30 mm23 (51.1)2 (40.0)1 (reference)
    ≥ 30 mm22 (48.9)3 (60.0)0.96 (0.46-2.00)
Shape0.254
    Regular24 (53.3)4 (80.0)1 (reference)
    Irregular21 (46.7)1 (20.0)2.35 (1.15-4.83)
Muscularis propria layer0.487
    Superficial41 (91.1)5 (100.0)1 (reference)
    Deep4 (8.9)0 (0.0)1.81 (0.87-3.78)
Histology0.336
    Leiomyoma or GIST with
low risk2
26 (57.8)4 (80.0)1 (reference)
    GIST with intermediate to
high risk3
19 (42.2)1 (20.0)0.92 (0.43-1.97)
Procedure type0.637
    Endoscopic resection422 (48.9)3 (60.0)1 (reference)
    LWR23 (51.1)2 (40.0)1.07 (0.22-5.28)
Long procedure< 0.001
    < 100 minutes41 (91.1)1 (20.0)1 (reference)
    ≥ 100 minutes4 (8.9)4 (80.0)0.96 (0.46-2.00)